Patent Assignment
Reel/Frame 060094/0426
Assignment of Assignor's Interest
Recorded: 2022-05-17
Pages: 73
Assignor
BIOGEN IDEC INTERNATIONAL HOLDING LTD.
Executed: 2013-08-19
Assignee
BIOGEN IDEC MA INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(2)
Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
Application:
17/745,409 →
Publication:
US 2023/0082238
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 17, 2022
From: YEDNOCK, THEODORE A.
To: ELAN PHARMACEUTICALS, INC.
Reel/Frame 059935/0304 →
Assignment of Assignor's Interest
May 17, 2022
From: ELAN PHARMACEUTICALS, INC.
To: BIOGEN IDEC INTERNATIONAL HOLDING LTD.
Reel/Frame 060092/0001 →
Change of Name
May 17, 2022
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 060101/0440 →